Standout Papers
Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing
2013
Nucleic acid detection with CRISPR-Cas13a/C2c2
2017 StandoutScience
Circulating Tumor DNA as a Liquid Biopsy for Cancer
2014
A Novel Platform for Detection of CK+ and CK− CTCs
2011
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
2016
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
ESR1 Methylation: A Liquid Biopsy–Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment
2017
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Hypoxia‐inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype
2016 StandoutNobel
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial
2018
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
2009
The dynamic range of circulating tumor DNA in metastatic breast cancer
2014
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
Cell-free circulating tumor DNA in cancer
2016
Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer
2015
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
2014 Standout
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
2013
A view on drug resistance in cancer
2019 StandoutNature
Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets
2013
Cancer to bone: a fatal attraction
2011 Standout
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
2018 StandoutNobel
Chemotaxis in cancer
2011
Pre-metastatic niches: organ-specific homes for metastases
2017
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
MicroRNAs are exported from malignant cells in customized particles
2012
Strictly Target Cell-dependent Activation of T Cells by Bispecific Single-chain Antibody Constructs of the BiTE Class
2007
In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells
2009
Integrating liquid biopsies into the management of cancer
2017
Impact of platinum‐based chemotherapy on circulating nucleic acid levels, protease activities in blood and disseminated tumor cells in bone marrow of ovarian cancer patients
2010
Tumor Cell Dissemination: Emerging Biological Insights from Animal Models and Cancer Patients
2013
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Challenges in circulating tumour cell research
2014
Metastatic Stem Cells: Sources, Niches, and Vital Pathways
2014
Characterization of extracellular circulating microRNA
2011 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer
2017
Liquid Biopsies, What We Do Not Know (Yet)
2017
Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
2013
Metastasis prevention by targeting the dormant niche
2015
Plasticity of disseminating cancer cells in patients with epithelial malignancies
2012
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Antitumour actions of interferons: implications for cancer therapy
2016
Circulating Tumor Cells as a Window on Metastasis Biology in Lung Cancer
2011
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Significance, detection and markers of disseminated breast cancer cells
2006
Breast Cancer Metastasis
2013
The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics
2016
Circulating tumour cells in cancer patients: challenges and perspectives
2010
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Targeting the function of the HER2 oncogene in human cancer therapeutics
2007
Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches
2011
Polymer Nanofiber‐Embedded Microchips for Detection, Isolation, and Molecular Analysis of Single Circulating Melanoma Cells
2013
Mechanisms Governing Metastatic Dormancy and Reactivation
2013
Clinical relevance of circulating cell-free microRNAs in cancer
2014
Cancer micrometastases
2009
Emerging Biological Principles of Metastasis
2017 Standout
EMT: 2016
2016 Standout
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
2016 Standout
Frequent expression of PD‐L1 on circulating breast cancer cells
2015
Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer
2014
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Lymphangiogenesis and lymphatic metastasis in breast cancer
2009
Molecular mechanisms of metastasis in breast cancer—clinical applications
2010
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Detection, clinical relevance and specific biological properties of disseminating tumour cells
2008
Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients
2012
Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives
2014
Clinical applications of the CellSearch platform in cancer patients
2018
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Cancer vaccines and carbohydrate epitopes
2011
High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients
2011
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
2016
A Noninvasive System for Monitoring Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors with Plasma DNA
2011
A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs)
2012
Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells
2010
Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer
2014
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Novel approaches to target the microenvironment of bone metastasis
2021
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
2015
Reliable and Sensitive Identification of Occult Tumor Cells Using the Improved Rare Event Imaging System
2004
SERS Nanoparticles in Medicine: From Label-Free Detection to Spectroscopic Tagging
2015
Identification and distinction of non-small-cell lung cancer cells by intracellular SERS nanoprobes
2016
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
Noncovalent Functionalization of Graphene and Graphene Oxide for Energy Materials, Biosensing, Catalytic, and Biomedical Applications
2016 Standout
Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells
2013
Engineered Proteins Pull Double Duty
2010
Molecular Pathways: Sensitivity and Resistance to Anti-EGFR Antibodies
2015
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Advances in the Application of Magnetic Nanoparticles for Sensing
2019
Circulating Tumor Cells in Breast Cancer: Detection Systems, Molecular Characterization, and Future Challenges
2012
Surface-Enhanced Raman Spectroscopy for Bioanalysis: Reliability and Challenges
2018 Standout
Disseminated Tumor Cells of Breast Cancer Patients: A Strong Prognostic Factor for Distant and Local Relapse
2008
Circulating tumor cells: approaches to isolation and characterization
2011
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
Circulating Tumor Cells in Breast Cancer:Detection Systems, Molecular Characterization, and Future Challenges
2011
A Method for Detecting Circulating Tumor Cells Based on the Measurement of Single‐Cell Metabolism in Droplet‐Based Microfluidics
2016
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Metabolic reprogramming and cancer progression
2020 StandoutScience
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Cancer Genome Landscapes
2013 StandoutScience
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Iron Oxide Based Nanoparticles for Multimodal Imaging and Magnetoresponsive Therapy
2015
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
2014
Capture of Viable Circulating Tumor Cells in the Liver of Colorectal Cancer Patients
2013
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Data Normalization Strategies for MicroRNA Quantification
2015
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Compact Biocompatible Quantum Dots Functionalized for Cellular Imaging
2008 StandoutNobel
Characterization of DNA Methylation in Circulating Tumor Cells
2015
Machine learning to detect signatures of disease in liquid biopsies – a user's guide
2017
Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients
2014
Magnetic‐Field‐Switchable Laser via Optical Pumping of Rubrene
2021 StandoutNobel
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Circulating Tumor Cells and Bone Marrow Micrometastasis
2008
Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer
2012
Emerging Droplet Microfluidics
2017 Standout
Atomically Precise Clusters of Noble Metals: Emerging Link between Atoms and Nanoparticles
2017 Standout
Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides
2020 StandoutNobel
Works of Brigitte Rack being referenced
Loss of Heterozygosity at Tumor Suppressor Genes Detectable on Fractionated Circulating Cell-Free Tumor DNA as Indicator of Breast Cancer Progression
2012
Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse—A European Pooled Analysis
2011
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer
2016
Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients
2011
Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase IIα, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow
2007
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
2010
The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer
2012
Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen–Friedenreich tumor antigen
2005
Patients with Recurrent Breast Cancer: Does the Primary Axillary Lymph node Status Predict more Aggressive Tumor Progression?
2003
Pooled Analysis of the Prognostic Relevance of Disseminated Tumor Cells in the Bone Marrow of Patients With Ovarian Cancer
2013
The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence
2005
Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression
2011
Immune Humanization of Immunodeficient Mice Using Diagnostic Bone Marrow Aspirates from Carcinoma Patients
2014
Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients
2014
Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
2010
Methylation patterns in serum DNA for early identification of disseminated breast cancer
2017
Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients
2013
Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus
2003
Detection of circulating tumor cells in different stages of prostate cancer
2013
Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program
2015
Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen
2008
Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas
2005
DNA methylation markers for early detection of women’s cancer: promise and challenges
2014
Aberrant plasma levels of circulatingmiR-16, miR-107, miR-130aandmiR-146aare associated with lymph node metastasis and receptor status of breast cancer patients
2015
Prognostic relevance of circulating tumor cells (CTCs) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy: The German SUCCESS-Trial
2008
Detection of Circulating Tumor Cells in Locally Advanced High-risk Prostate Cancer During Neoadjuvant Chemotherapy and Radical Prostatectomy.
2015
Effect of zoledronate on persisting isolated tumour cells in patients with early breast cancer.
2010
Liquid biopsy-based clinical research in early breast cancer: The EORTC 90091-10093 Treat CTC trial
2016
Use of circulating tumor cells (CTC) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy to predict risk for relapse: The SUCCESS trial.
2010
Detection of Micrometastatic Disease in Bone Marrow: Is It Ready for Prime Time?
2005
Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System
2007
Phase I Trial of the Trifunctional Anti-HER2 × Anti-CD3 Antibody Ertumaxomab in Metastatic Breast Cancer
2006
Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis
2018
Circulating tumor cells (CTCs) in peripheral blood of primary breast cancer patients
2007